A retrospective review was performed on 125 patients diagnosed with primary carcinoma of the head and neck who received conventional 3-field postoperative definitive radiation therapy at the ...

Cancer is a disease that affects millions of people around the world, and treating it often involves tough decisions. One of ...

A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...

Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those with p16-negative tumors.

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of ...

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

De-escalation strategies such as NECTORS offer a potential alternative by addressing micrometastasis while sparing patients from radiation-related side effects. To assess the potential survival ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

The TrueBeam Linear Accelerator's RapidArc technology is effective in treating diseases such as breast cancer, prostate cancer, lung, head and neck cancer. It has the ability to target the tumour ...